By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Gilead Sciences and the Yale School of Medicine today announced a collaboration to explore the genetic basis and molecular mechanisms of cancer in order to develop new cancer therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.